GlassScriptLipiflow System Activator (Disposable)
Payments companies reported to CMS as associated with Lipiflow System Activator (Disposable). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lipiflow System Activator (Disposable), per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lipiflow System Activator (Disposable)
These are the largest totals companies reported as associated with Lipiflow System Activator (Disposable). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ryan Smith | Upland, CA | Ophthalmology | $25,868.83 |
| Ryan Beck | Boca Raton, FL | Optometrist | $13,721.99 |
| Todd Cohan | Long Grove, IL | Optometrist | $11,026.64 |
| Nicole Fram | Los Angeles, CA | Ophthalmology | $7,637.50 |
| Deborah Ristvedt | Alexandria, MN | Ophthalmology | $4,550.00 |
| Julio Albarracin | Dallas, TX | Ophthalmology | $4,375.00 |
| Kambiz Silani | Beverly Hills, CA | Corneal and Contact Management | $4,298.59 |
| Casey Claypool | Spokane Valley, WA | Optometrist | $4,125.12 |
| David Kading | Kirkland, WA | Optometrist | $3,988.09 |
| Ashraf Ahmad | Irvine, CA | Ophthalmology | $3,841.20 |
Prescribed Lipiflow System Activator (Disposable)?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.